AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2016
Dec 9, 2016
3174_iss_2016-12-09_540bc240-3563-402e-b4e7-8232decd86cc.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Nordnet AB (publ)
Instrument
| Instrument Aktier SE0003613090 |
|
|---|---|
| Before the transaction | |
| Shares 448,528 |
|
| Voting rights 448,528 |
|
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date 07/12/2016 |
|
| Limit for number of shares 5 % |
|
| Limit for number of votes 5 % |
|
| After the transaction | |
| Quantity | |
| Shares 805,105 |
|
| Directly held voting rights 0 |
|
| Indirectly held voting rights 805,105 |
|
| Percentage | |
| Directly held shares 5.1 % |
|
| Directly held voting rights 0 % |
|
| Indirectly held voting rights 5.1 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.1 % | 805,105 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5.1 % | 805,105 |
Chain of controlling companies
| Voting rights % Voting rights Company | ||
|---|---|---|
| 805,105 | 5.1 | Nordnet Pensionsförsäkring AB |
Group total holdings Voting rights 805,105
Percentage of voting rights 5.1
Notes (other relevant informations according to law)
Nordnet AB genom Nordnet Pensionsförsäkring AB har överskridit tröskelvärdet 5 % av antal utestående röster och aktier till följd av nettoköp i Moberg Pharma AB.
Published
09/12/2016 10:16
Contact
Name Rasmus Rainio Reivilä
Phone 08-50633463 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13